# Phase 24 — Trust, Security & Compliance Readiness

## Purpose

Phase 24 packages the evidence and control model needed for independent security, privacy, clinical, and IP diligence.

## Acceptance criteria

- A threat model covers authentication, tenant isolation, uploads, retrieval, deletion, telemetry, and external providers.
- Privacy controls cover data mapping, retention, deletion, residency, vendor processing, and backup handling.
- Security controls have explicit owners and evidence references.
- AI safety review covers prompt injection, hallucination, provenance, unsafe escalation, and unsupported claims.
- Clinical review is required before any feature makes clinical claims.
- IP review covers contributors, dependencies, models, datasets, medical content, and historical artifacts.
- Incident response, backup/restore, and deployment evidence are identified and reviewable.
- Compliance language remains evidence-based: readiness controls are not certifications; Phase 24 is not a certification.

## Control matrix

The machine-readable controls in `src/core/compliance.py` provide stable identifiers for privacy, security, medical-AI safety, IP, operations, and production evidence.

## Explicit non-claims

Passing Phase 24 does **not** mean HIPAA, PIPEDA, PHIPA, GDPR, SOC 2, medical-device, or regulatory certification. It means the repository has a structured diligence boundary and does not confuse source-code controls with organizational or legal compliance.

## Exit condition

The repository phase is complete when the control matrix, evidence-boundary tests, safety documentation, and CI gate pass. Independent assessments and legal/clinical determinations remain external.
